Shares of PureTech Health plc (OTCMKTS:PTCHF – Get Free Report) fell 2% on Tuesday. The stock traded as low as $1.4450 and last traded at $1.51. Approximately 11,775 shares were traded during mid-day trading, a decline of 65% from the average daily volume of 34,122 shares. The stock had previously closed at $1.5410.
PureTech Health Stock Performance
The firm has a fifty day simple moving average of $1.57 and a 200-day simple moving average of $1.64.
PureTech Health Company Profile
PureTech Health plc is a biopharmaceutical company that develops medicines for complex diseases, with a focus on therapeutic approaches designed to address significant unmet patient needs. The company combines its own research and development activities with a model of creating, financing and advancing subsidiary companies that pursue distinct therapeutic programs.
PureTech’s research platform includes orally administered medicines and other treatments intended to influence biological pathways that are difficult to target with conventional drug-delivery methods.
Further Reading
- Five stocks we like better than PureTech Health
- Want Private-Market Access to Kalshi and Polymarket? Try This ETF
- Levi’s Stock Dip Reveals Value Opportunity Despite Q3 Headwinds
- PepsiCo Stock Looks Poised to Bottom With High Yield, Deep Value
- Alphabet’s $1.8 Billion Black Hills Deal Powers AI Data Center Push
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
